Detalles de la búsqueda
1.
Plasma extracellular vesicles reveal early molecular differences in amyloid positive patients with early-onset mild cognitive impairment.
J Nanobiotechnology;
21(1): 54, 2023 Feb 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36788617
2.
The Synergic Effect of AT(N) Profiles and Depression on the Risk of Conversion to Dementia in Patients with Mild Cognitive Impairment.
Int J Mol Sci;
24(2)2023 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36674881
3.
Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project.
Alzheimers Dement;
15(10): 1333-1347, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31473137
4.
Exploring APOE genotype effects on Alzheimer's disease risk and amyloid ß burden in individuals with subjective cognitive decline: The FundacioACE Healthy Brain Initiative (FACEHBI) study baseline results.
Alzheimers Dement;
14(5): 634-643, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29156223
5.
Macular vessel density in the superficial plexus is not a proxy of cerebrovascular damage in non-demented individuals: data from the NORFACE cohort.
Alzheimers Res Ther;
16(1): 42, 2024 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38378643
6.
Macular vessel density in the superficial plexus is not associated to cerebrospinal fluid core biomarkers for Alzheimer's disease in individuals with mild cognitive impairment: The NORFACE cohort.
Front Neurosci;
17: 1076177, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36908784
7.
A randomized, open-label clinical trial in mild cognitive impairment with EGb 761 examining blood markers of inflammation and oxidative stress.
Sci Rep;
13(1): 5406, 2023 04 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37012306
8.
Automatized FACEmemory® scoring is related to Alzheimer's disease phenotype and biomarkers in early-onset mild cognitive impairment: the BIOFACE cohort.
Alzheimers Res Ther;
14(1): 43, 2022 03 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35303916
9.
Differences in macular vessel density in the superficial plexus across cognitive impairment: the NORFACE cohort.
Sci Rep;
12(1): 16938, 2022 10 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36209290
10.
From Face-to-Face to Home-to-Home: Validity of a Teleneuropsychological Battery.
J Alzheimers Dis;
81(4): 1541-1553, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33935075
11.
Neuropsychiatric profiles and conversion to dementia in mild cognitive impairment, a latent class analysis.
Sci Rep;
11(1): 6448, 2021 03 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-33742011
12.
BIOFACE: A Prospective Study of Risk Factors, Cognition, and Biomarkers in a Cohort of Individuals with Early-Onset Mild Cognitive Impairment. Study Rationale and Research Protocols.
J Alzheimers Dis;
83(3): 1233-1249, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34420953
13.
Neuropsychiatric Profile as a Predictor of Cognitive Decline in Mild Cognitive Impairment.
Front Aging Neurosci;
13: 718949, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34955804
14.
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores.
Nat Commun;
12(1): 3417, 2021 06 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34099642
15.
Personality Factors and Subjective Cognitive Decline: The FACEHBI Cohort.
Behav Neurol;
2020: 5232184, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32148563
16.
Managing Clinical Trials for Alzheimer's Disease During the COVID-19 Crisis: Experience at Fundació ACE in Barcelona, Spain.
J Alzheimers Dis;
77(4): 1805-1813, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32986671
17.
Subtle executive deficits are associated with higher brain amyloid burden and lower cortical volume in subjective cognitive decline: the FACEHBI cohort.
Sci Rep;
10(1): 17721, 2020 10 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33082443
18.
Interaction of neuropsychiatric symptoms with APOE ε4 and conversion to dementia in MCI patients in a Memory Clinic.
Sci Rep;
10(1): 20058, 2020 11 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33208795
19.
A computerized version of the Short Form of the Face-Name Associative Memory Exam (FACEmemory®) for the early detection of Alzheimer's disease.
Alzheimers Res Ther;
12(1): 25, 2020 03 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-32178724
20.
Evaluation of macular thickness and volume tested by optical coherence tomography as biomarkers for Alzheimer's disease in a memory clinic.
Sci Rep;
10(1): 1580, 2020 01 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-32005868